Jean-Pierre Sommadossi is President, Chief Executive Officer and Chairman of the Board of Atea Pharmaceuticals, Inc. (AVIR). The company reported total compensation of $3,403,752 for fiscal year 2025.
| Salary | $703,490 |
|---|---|
| Bonus | $0 |
| Stock awards | $1,315,800 |
| Option awards | $962,368 |
| Non-equity incentive plan | $422,094 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $0 |
| Total | $3,403,752 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Atea Pharmaceuticals, Inc. filed April 27, 2026, accession 0001193125-26-182293.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, Chief Executive Officer and Chairman of the Board | $703,490 | $0 | $1,315,800 | $962,368 | $422,094 | $0 | $0 | $3,403,752 |
| FY2024 | President, Chief Executive Officer and Chairman of the Board | $703,490 | $0 | $1,788,800 | $1,372,358 | $337,675 | $0 | $0 | $4,202,323 |
| FY2023 | President, Chief Executive Officer and Chairman of the Board | $683,000 | — | $2,409,452 | $2,474,763 | $358,575 | — | — | $5,925,790 |
Totals as disclosed in each year's own compensation disclosure for Atea Pharmaceuticals, Inc..
| Peer-group chief executive median | $2,669,332 |
|---|---|
| Difference from that median | $734,421 |
| Percentile within the disclosed peer group | 56th |
| Peers with a disclosed figure | 16 |
Medians and percentiles are computed across the peer group Atea Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jean-Pierre Sommadossi this page | President, Chief Executive Officer and Chairman of the Board | $3,403,752 |
| Janet Hammond | Chief Development Officer | $1,767,234 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal, and Secretary | $1,690,428 |
| Maria Arantxa Horga | Chief Medical Officer | $1,593,827 |
| John Vavricka | Chief Commercial Officer | $1,217,738 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Atea Pharmaceuticals, Inc. compensation brief.
Jean-Pierre Sommadossi's compensation sits inside Atea Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.